Cargando…
Immune therapy of metastatic melanoma developing after allogeneic bone marrow transplant
Metastatic melanoma is frequently treated with immune activating therapy, which poses a theoretical risk of inducing graft versus host disease (GVHD) in those who have received allogeneic stem cell transplantation. The literature reporting the safety of immunotherapy in post transplant patients is l...
Autores principales: | Cecchini, Michael, Sznol, Mario, Seropian, Stuart |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372324/ https://www.ncbi.nlm.nih.gov/pubmed/25806109 http://dx.doi.org/10.1186/s40425-015-0054-4 |
Ejemplares similares
-
Bronchiolitis Obliterans after Allogenic Bone Marrow Transplantation: HRCT Findings
por: Jung, Jung Im, et al.
Publicado: (2004) -
PSAT341 Hashimoto's Thyroiditis After Allogenic Bone Marrow Transplantation
por: Melhim, Abdullah, et al.
Publicado: (2022) -
Bronchiolitis Obliterans With Recurrent Pneumothorax After Allogeneic Bone Marrow Transplantation
por: Akatsuka, Masayuki, et al.
Publicado: (2023) -
LRBA is Essential for Allogeneic Responses in Bone Marrow Transplantation
por: Park, Mi Young, et al.
Publicado: (2016) -
Bone Marrow GvHD after Allogeneic Hematopoietic Stem Cell Transplantation
por: Szyska, Martin, et al.
Publicado: (2016)